These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29197406)

  • 1. Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease.
    Du T; Sun X; Yu X
    Lipids Health Dis; 2017 Dec; 16(1):229. PubMed ID: 29197406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
    Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
    Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males.
    Peng K; Mo Z; Tian G
    Am J Med Sci; 2017 Mar; 353(3):236-241. PubMed ID: 28262209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research.
    Chen Z; Qin H; Qiu S; Chen G; Chen Y
    Lipids Health Dis; 2019 Aug; 18(1):162. PubMed ID: 31399032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B is not superior to non-high-density lipoprotein cholesterol for dyslipidemic classification of glycated hemoglobin-defined diabetic patients.
    Xie J; Hu S
    Medicine (Baltimore); 2018 Oct; 97(42):e12896. PubMed ID: 30335016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study.
    Fan N; Peng L; Xia Z; Zhang L; Song Z; Wang Y; Peng Y
    Lipids Health Dis; 2019 Feb; 18(1):39. PubMed ID: 30711017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
    Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors.
    Du T; Sun X; Yuan G; Zhou X; Lu H; Lin X; Yu X
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):63-69. PubMed ID: 27956025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol.
    Wu KT; Kuo PL; Su SB; Chen YY; Yeh ML; Huang CI; Yang JF; Lin CI; Hsieh MH; Hsieh MY; Huang CF; Lin WY; Yu ML; Dai CY; Wang HY
    J Clin Lipidol; 2016; 10(2):420-5.e1. PubMed ID: 27055973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.
    Dowla S; Aslibekyan S; Goss A; Fontaine K; Ashraf AP
    J Clin Lipidol; 2018; 12(4):981-987. PubMed ID: 29699915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test.
    Hou X; Guan Y; Tang Y; Song A; Zhao J; Ren L; Chen S; Wei L; Ma H; Song G
    Lipids Health Dis; 2021 May; 20(1):54. PubMed ID: 34034748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
    Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
    Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
    Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
    Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study.
    Zou Y; Zhong L; Hu C; Zhong M; Peng N; Sheng G
    Lipids Health Dis; 2021 Mar; 20(1):28. PubMed ID: 33766067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction.
    Haberka M; Okopień B; Gąsior Z
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.